Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in Asia

BACKGROUND AND PURPOSE: The rate of donepezil discontinuation and the underlying reasons for discontinuation in Asian patients with Alzheimer's disease (AD) are currently unknown. We aimed to determine the treatment discontinuation rates in AD patients who had newly been prescribed donepezil in...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Kee Hyung, Yang, YoungSoon, Chen, Christopher, Shim, Yong S., Domingueze, Jacqueline C., Lee, Chan-Nyoung, Kang, Kyunghun, Kim, Hee-Jin, Jeong, Seul-Ki, Jeong, Jee Hyang, Hong, Zhen, Yoon, Soo Jin, Zhang, Zhen-Xin, Kim, Eun-Joo, Jang, Jae-Won, Li, Yansheng, Xu, Yun, Lin, Yu-Te, Qu, Qiumin, Hu, Chaur-Jong, Chou, Chih-Ho, Fan, Dongsheng, Kandiah, Nagaendran, Yang, Yuan-Han, Lau, Chi-ieong, Chu, Leung-Wing, Wang, Huali, Jung, San, Choi, Seong Hye, Kim, SangYun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242303/
https://www.ncbi.nlm.nih.gov/pubmed/34184445
http://dx.doi.org/10.3988/jcn.2021.17.3.376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242303/
https://www.ncbi.nlm.nih.gov/pubmed/34184445
http://dx.doi.org/10.3988/jcn.2021.17.3.376

Ejemplares similares